Lauras As

Kjetil Taskén

Jo Klaveness

Pål Aukrust

Vidar Hansson

Stig S Frøland

Einar Martin Aandahl

Vidar Bjørnstad

Kjell Undheim

Michel Moutschen

Christian C Johansson

Bjørn S Skålhegg

Geir Langli

Souad Rahmouni-Piette

Fredrik Müller

This invention provides novel 8-carbyl substituted cAMPS and a novel procedures for the preparation of 8-Br-cAMP, a key starting material.

Purine nucleotide derivatives

The present invention provides a method of treating or preventing a disorder typified by an immunodificiency (e.g. HIV), wherein the patient is administered a COX-2 inhibitor or derivative or pharmaceutically acceptable salt thereof, preferably diisopropylfluorophasphate. L-745337, rofecoxib, NS 398, SC 58125, etodolac, meloxicam, celecoxib or nimesulide, and compositions and products containing the same or use of the same in preparing medicaments and for treatment.

Methods of treating and preventing AIDS using of COX-2 inhibitors

Pharmaceutical compositions useful for treating immunosuppressive disease and containing compounds capable of inhibiting cAMP-dependent protein kinase A (PKA) as well as use of the same, are described.

Use of immunomodulating agents

Growing community of inventors

Rykkinn, Norway

Kjetil Taskén